Home

 Company Profile News & Events Scientific Programme Licensing AIM Rule 26 Feedback Contact Us
 
 

Pharmaceutical Products

          Pharmaceutical- Ionic Contra Viral Therapy (ICVT)
  Overview
Formulation Studies
Ophthalmic Disease
Skin Warts And Verrucae (Plantar Warts)
Genital Warts
Herpes And Dysplastic Disease
Recurrent Respiratory Papilloma
Animal Health
Other
 
   
Biological Products
  Biologics
Overview of Biologics
• Preps And L-Particles
   o Simple Description
   o More Complex Description
      • Overview
      • Herpes Simplex Vaccine
      • Other Herpes Virus Vaccine
      • Cancer Immunotherapeutic
      • Other Uses
         o Stem cell study

Koi Herpes Vaccine
 
 
 
 

Ionic Contraviral Therapy- ICVT

Genital Warts
Genital warts result from infection of the genital tissues in either men or women by strains of HPV. These are exceedingly common, and it has been estimated that 80% of American women will have HPV genital infection at some time between the ages of 15 and 50.

Once again current treatment strategies are sub-optimal requiring either surgical removal and lesion destruction, or by application of expensive immune modulators which are not without adverse effects. Henderson Morley is developing a specific formulation to apply to genital lesions and clinical trials will be started once the pre-clinical work has been completed.

Next: Herpes And Dysplastic Disease
 

 

Home | Company Profile  | News & Events  | Scientific Programme | Licensing  | Investor Relations  | Feedback  | Contact Us